UA
GILD icon

Unison Advisors’s Gilead Sciences GILD Stock Holding History

Unison Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22,395
Closed -$1.68M – 184
2023
Q3 		$1.68M Buy
22,395
+215
+1% +$16.5K 0.2% 66
2023
Q2 		$1.71M Buy
22,180
+198
+0.9% +$15.8K 0.19% 65
2023
Q1 		$1.82M Buy
21,982
+224
+1% +$18.6K 0.2% 62
2022
Q4 		$1.87M Buy
21,758
+254
+1% +$20.1K 0.24% 60
2022
Q3 		$1.33M Buy
21,504
+246
+1% +$15.5K 0.25% 69
2022
Q2 		$1.31M Buy
21,258
+255
+1% +$15.8K 0.34% 64
2022
Q1 		$1.25M Buy
21,003
+202
+1% +$12.9K 0.3% 69
2021
Q4 		$1.51M Buy
20,801
+266
+1% +$18.3K 0.36% 62
2021
Q3 		$1.44M Sell
20,535
-5,055
-20% -$355K 0.36% 65
2021
Q2 		$1.76M Buy
25,590
+2,441
+11% +$163K 0.33% 67
2021
Q1 		$1.5M Buy
23,149
+246
+1% +$15.9K 0.29% 68
2020
Q4 		$1.33M Buy
22,903
+246
+1% +$14.8K 0.3% 70
2020
Q3 		$1.43M Buy
22,657
+190
+0.8% +$13.2K 0.41% 63
2020
Q2 		$1.73M Buy
22,467
+3,948
+21% +$303K 0.58% 59
2020
Q1 		$1.39M Buy
18,519
+177
+1% +$12.2K 1.49% 16
2019
Q4 		$1.19M Buy
18,342
+177
+1% +$11.5K 0.86% 53
2019
Q3 		$1.15M Buy
18,165
+169
+0.9% +$11K 0.89% 54
2019
Q2 		$1.22M Buy
17,996
+170
+1% +$11.2K 0.92% 48
2019
Q1 		$1.16M Buy
17,826
+147
+0.8% +$9.77K 0.86% 52
2018
Q4 		$1.11M Buy
17,679
+127
+0.7% +$8.88K 0.88% 45
2018
Q3 		$1.35M Buy
17,552
+128
+0.7% +$9.67K 0.95% 38
2018
Q2 		$1.23M Buy
17,424
+134
+0.8% +$9.46K 0.91% 42
2018
Q1 		$1.3M Buy
17,290
+114
+0.7% +$9.06K 0.98% 34
2017
Q4 		$1.23M Buy
+17,176
New +$1.3M 0.9% 50

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Unison Advisors's GILD Position: Q4 2023 in Review

Unison Advisors sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 22,395 shares — an estimated $1.68M sold.

Unison Advisors first reported a position in GILD in Q4 2017 and held it in 24 quarters. The position peaked at $1.87M in Q4 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Unison Advisors reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Unison Advisors sold 22,395 Gilead Sciences shares in Q4 2023, an estimated $1.68M.
  • Unison Advisors first reported a position in Gilead Sciences in Q4 2017 and held it in 24 quarters.
  • Unison Advisors's Gilead Sciences position peaked at $1.87M in Q4 2022.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Unison Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.